- Home
- MMA vs ADAP Comparison
MMA vs ADAP Comparison
Compare MMA & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- ADAP
- Stock Information
- Founded
- MMA 2013
- ADAP 2008
- Country
- MMA Australia
- ADAP United Kingdom
- Employees
- MMA N/A
- ADAP N/A
- Industry
- MMA
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- ADAP Health Care
- Exchange
- MMA Nasdaq
- ADAP Nasdaq
- Market Cap
- MMA 20.1M
- ADAP 21.3M
- IPO Year
- MMA 2024
- ADAP 2015
- Fundamental
- Price
- MMA $1.41
- ADAP $0.20
- Analyst Decision
- MMA
- ADAP Hold
- Analyst Count
- MMA 0
- ADAP 6
- Target Price
- MMA N/A
- ADAP $1.02
- AVG Volume (30 Days)
- MMA 374.8K
- ADAP 97.2M
- Earning Date
- MMA 01-01-0001
- ADAP 11-12-2025
- Dividend Yield
- MMA N/A
- ADAP N/A
- EPS Growth
- MMA N/A
- ADAP N/A
- EPS
- MMA N/A
- ADAP N/A
- Revenue
- MMA $407,412.00
- ADAP $65,084,999.00
- Revenue This Year
- MMA N/A
- ADAP N/A
- Revenue Next Year
- MMA N/A
- ADAP $24.70
- P/E Ratio
- MMA N/A
- ADAP N/A
- Revenue Growth
- MMA N/A
- ADAP N/A
- 52 Week Low
- MMA $0.60
- ADAP $0.04
- 52 Week High
- MMA $4.11
- ADAP $0.88
- Technical
- Relative Strength Index (RSI)
- MMA 48.96
- ADAP 61.92
- Support Level
- MMA $1.39
- ADAP $0.15
- Resistance Level
- MMA $1.70
- ADAP $0.24
- Average True Range (ATR)
- MMA 0.11
- ADAP 0.03
- MACD
- MMA -0.04
- ADAP 0.00
- Stochastic Oscillator
- MMA 6.06
- ADAP 55.59
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.